Potential Mechanism of Herb-Drug Interaction Mediated by Angelica dahurica: Inhibition on CYP3A Enzymes in Rats

Yang, Fan and Mussa, Ally R. and An, Lijun and Liang, Rongjia and Shi, Xiaoyan and Kabera, Justin N. and He, Xin (2016) Potential Mechanism of Herb-Drug Interaction Mediated by Angelica dahurica: Inhibition on CYP3A Enzymes in Rats. Pharmacology & Pharmacy, 07 (04). pp. 153-161. ISSN 2157-9423

[thumbnail of PP_2016042010585131.pdf] Text
PP_2016042010585131.pdf - Published Version

Download (714kB)

Abstract

Angelica dahurica is commonly referred to as ‘Baizhi’ in China and has been noted for its therapeutic significance. The major active ingredients of Angelica dahurica is coumarin, which is reported as a kind of potent inhibitor of cytochrome P450 enzymes (CYP450s). The aim of this study was to investigate the inhibition of CYP3A enzymes by total coumarin extract (TCE) obtained from dried root of Angelica dahurica by using in situ single pass intestinal perfusion (SPIP) and in situ liver perfusion in rats. When midazolam (MDZ) which is a substrate of CYP3A co-perfused with TCE (198 μg/mL) from Baizhi in duodenum and ileum segments, the Peff of MDZ has increased significantly compared with the MDZ single perfused group (p < 0.01) (n = 6). However, there was no significant effect on Peff of MDZ when it co-perfused with 66 μg/mL of TCE from Baizhi in both segments (p > 0.05) (n = 6). During in situ liver perfusion study, the results demonstrated that, 3 days oral administration of TCE obtained from Baizhi could significantly reduce the elimination rate of MDZ in the perfusate (p < 0.05) (n = 3). This study revealed that TCE from Baizhi had potent inhibition on CYP3A enzymes, and the inhibitory effect was related to dose. Therefore, when Angelica dahurica extract co-administrated with drugs which are the substrates of CYP3A, much more attention should be paid rather than that of other CYP450 enzymes. These findings may facilitate in predicting possible herb-drug interactions (HDIs) when Angelica dahurica is used in combination with other drugs, and decrease the incidence of the CYP450-mediated HDIs.

Item Type: Article
Subjects: Science Global Plos > Chemical Science
Depositing User: Unnamed user with email support@science.globalplos.com
Date Deposited: 06 Mar 2023 11:21
Last Modified: 30 Dec 2023 13:32
URI: http://ebooks.manu2sent.com/id/eprint/195

Actions (login required)

View Item
View Item